Literature DB >> 8376778

Human mast cells produce IL-8.

A Möller1, U Lippert, D Lessmann, G Kolde, K Hamann, P Welker, D Schadendorf, T Rosenbach, T Luger, B M Czarnetzki.   

Abstract

Recruitment of neutrophils is a common feature in diseases that are associated with mast cell activation. The mechanisms that mediate neutrophil activation are not well understood. IL-8 is a recently described potent chemotactic factor that might be pathogenetically involved in this process. We therefore studied the human mast cell line HMCI and human skin mast cells for their ability to produce IL-8 using various stimuli. IL-8-mRNA was expressed in a stimulus- and time-dependent fashion as detected by Northern blot analysis with an IL-8-specific cDNA probe. The molecular mass of HMCI-derived IL-8 was determined to be about 8 kDa by immunoblot analysis. Immunoreactive and biologically active IL-8 protein was measured in the cell culture supernatants of HMCI cells by an ELISA and a chemotaxis assay, respectively. On immunoelectron microscopy of stimulated skin mast cells, IL-8 was found along cytoplasmatic membranes and in intracellular granules. Our data indicate that mast cells may contribute to neutrophil recruitment by secretion of IL-8.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376778

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line.

Authors:  C A King; J S Marshall; H Alshurafa; R Anderson
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 2.  Importance of mast cells in the pathophysiology of asthma.

Authors:  Seong H Cho; Andrea J Anderson; Chad K Oh
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

Review 3.  The diverse effects of mast cell mediators.

Authors:  Colleen Hines
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

Review 4.  Ocular mast cells. Characterization in normal and disease states.

Authors:  E B Cook; J L Stahl; N P Barney; F M Graziano
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

5.  Serial morphologic observation of bone marrow in aplastic anemia in children.

Authors:  Fumio Bessho; Shinsaku Imashuku; Shigeyoshi Hibi; Masahiro Tsuchida; Tatsutoshi Nakahata; Sumio Miyazaki; Seiji Kojima; Ichiro Tsukimoto; Nobuyuki Hamajima
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

6.  Differential response of human basophils and mast cells to recombinant chemokines.

Authors:  W Füreder; H Agis; H Semper; F Keil; U Maier; M R Müller; K Czerwenka; H Höfler; K Lechner; P Valent
Journal:  Ann Hematol       Date:  1995-05       Impact factor: 3.673

7.  Substance P-induced inflammatory responses in guinea-pig skin: the effect of specific NK1 receptor antagonists and the role of endogenous mediators.

Authors:  D T Walsh; V B Weg; T J Williams; S Nourshargh
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

8.  Interleukin 8 and mast cell-generated tumor necrosis factor-alpha in neutrophil recruitment.

Authors:  Y Zhang; B F Ramos; B Jakschik; M P Baganoff; C L Deppeler; D M Meyer; D L Widomski; D J Fretland; M A Bolanowski
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

9.  IL-4 enhances IL-3 and IL-8 gene expression in a human leukemic mast cell line.

Authors:  M G Buckley; C M Williams; J Thompson; P Pryor; K Ray; J H Butterfield; J W Coleman
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

10.  Polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of pro-inflammatory cytokines by inhibiting the activation of MAP Kinases and NF-kappaB in human KU812 cells.

Authors:  Zafar Rasheed; Nahid Akhtar; Arivarasu N Anbazhagan; Sangeetha Ramamurthy; Meenakshi Shukla; Tariq M Haqqi
Journal:  J Inflamm (Lond)       Date:  2009-01-08       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.